Screener
Kyntra Bio KYNB Q1 2026 earnings
Reported May 11, 2026 · After market close
Revenue$3.7MBeat by $2.1M
EPS-$3.74Miss by $0.38
Revenue estimate$1.6M
EPS estimate-$3.36
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$1.8M
EPS estimate-$3.66
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Kyntra Bio report Q1 2026 earnings?
- Kyntra Bio (KYNB) reported Q1 2026 earnings on May 11, 2026 after market close.
- What were Kyntra Bio's Q1 2026 revenue and EPS?
- Kyntra Bio reported revenue of $3.7M and eps of $-3.74 for Q1 2026.
- Did Kyntra Bio beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $1.6M by $2.1M. EPS missed the consensus estimate of $-3.36 by $0.38.
- How did Kyntra Bio's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 35.1% from $2.7M a year earlier and eps grew 6.5% from $-4.00.
- Where can I find Kyntra Bio's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-216731) and the 10-Q periodic report (0001193125-26-219374) directly on SEC EDGAR. The filing index links above go to sec.gov.
